AAV8 variant (Y733F,Y447F) Rep-Cap plasmid (Pancreas and reina-validated serotype AAV-RC plasmid)
Capsid mutant-AAV serotype 8 variant (AAV8-(Y733F,Y447F) system - Introduction
GeneMedi's AAV8-2m Rep-Cap plasmid (retina-validated serotype AAV-RC plasmid), also named AAV8-2m-RC plasmid, is part of AAV8-2m packaging system. AAV8-2m Rep-Cap plamid supplies the AAV8 Rep(replication) proteins and the AAV8-2m capsid protein.
You can produce AAV8-2m paticle in 293T cell line in high titer using GeneMedi's AAV8-2m Rep-Cap plasmid with GeneMedi's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
The tissue tropism of AAV8 variant(Y733F,Y447F) vector has been validated in in Pancreas and retina,with potential applications in tissue-specific gene therapy and cancer therapy.
|Product Name||Contents||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|AAV8-2m Rep-Cap plasmid||Serotype: AAV8-2m
AAV8 capsid variant (Y733F, Y447F) tissue tropism and gene transduction
(serotype-specific AAV infection)
The tissue tropism of AAV8-2m vector has been validated in in Pancreas and retina,with potential applications in tissue-specific gene therapy and cancer therapy.
Virus and titer: AAV1/AAV6/AAV8/AAV-Rh10/AAV-DJ/AAV9-GFP, 1×1012 vg/ml Cells: HEK-293T MOI: MOI=1×104 Determine assay: 36 hours post infection, immunofluorescence microscopy
Other AAV Rep-Cap Plasmid